Sample size determination in clinical proteomic profiling experiments using mass spectrometry for class comparison.
Mass spectrometric profiling approaches such as MALDI-TOF and SELDI-TOF are increasingly being used in disease marker discovery, particularly in the lower molecular weight proteome. However, little consideration has been given to the issue of sample size in experimental design. The aim of this study was to develop a protocol for the use of sample size calculations in proteomic profiling studies using MS. These sample size calculations can be based on a simple linear mixed model which allows the inclusion of estimates of biological and technical variation inherent in the experiment. The use of a pilot experiment to estimate these components of variance is investigated and is shown to work well when compared with larger studies. Examination of data from a number of studies using different sample types and different chromatographic surfaces shows the need for sample- and preparation-specific sample size calculations.
Cairns
David A
DA
Clinical and Biomedical Proteomics Group, Cancer Research UK Clinical Centre, Leeds Institute of Molecular Medicine, St. James's University Hospital, Leeds, UK. d.a.cairns@leeds.ac.uk
Barrett
Jennifer H
JH
Billingham
Lucinda J
LJ
Stanley
Anthea J
AJ
Xinarianos
George
G
Field
John K
JK
Johnson
Phillip J
PJ
Selby
Peter J
PJ
Banks
Rosamonde E
RE
D000704:Analysis of Variance; D001798:Blood Proteins / Q000032:analysis; D006801:Humans; D013058:Mass Spectrometry; D010949:Plasma / Q000737:chemistry; D040081:Protein Array Analysis / Q000379:methods*; D020543:Proteome / Q000032:analysis*; D012107:Research Design; D018401:Sample Size
D001798:Blood Proteins; D020543:Proteome